key updates in mds from ash on magrolimab, sabatolimab, venetoclax & tamibarotene
Published 1 year ago • 164 plays • Length 2:00Download video MP4
Download video MP3
Similar videos
-
2:00
key mds updates from the 2021 ash meeting
-
3:19
key clinical trials in mds taking place in the us
-
1:23
the current landscape of treatment for hr-mds: an update from ash 2023
-
1:22
key advances in mds management
-
2:09
trends in aml and mds at ash 2021
-
1:06
ongoing mds clinical trials to look out for
-
2:14:43
sdp: introduction to the concept of itsm, versions, licensing and integrations
-
6:44
enc 2023: fungiscope - global fungal infection registry
-
38:15
section i and j updates
-
4:40
all at ash: four key updates
-
1:18
key recurrent mutations in mds
-
1:52
advances in lr-mds and hr-mds in 2023 and beyond
-
1:22
mds updates from ash 2019
-
3:10
the role of ngs in mds diagnosis
-
2:16
current and future treatment approaches for hr-mds
-
1:36
clinical trials evaluating novel agents in mds: select-mds-1
-
1:23
developing a pro collection tool for patients with scd: key themes which are important to patients
-
2:14
guidance on mutational testing for diagnosing and monitoring cml
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
2:33
what can artificial intelligence bring to the diagnosis and management of mds?
-
2:01
updates in mds diagnosis and prognosis with the ipss-m: personalized medicine in 2023